Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose

Industrial biotech specialist Ingenza is delighted to announce that it is collaborating with Cellugy to accelerate the development of its innovative platform for producing biofabricated cellulose. This technology will provide a sustainable alternative to fossil-based petrochemicals in various industrial applications, starting with personal care. The new project will ultimately accelerate the understanding and optimisation of bacterial cellulose production.

Cellugy, a Denmark-based start-up, was established in 2018 to create high performance, fully bio-based and biodegradable ingredients using the power of cellulose-producing microorganisms, with the aim of reducing reliance on petrochemicals for a healthier and safer planet. This collaboration allows Cellugy to benefit from Ingenza's extensive experience in the study of diverse microorganisms, and will focus on implementing different techniques to identify key factors influencing the cellulose production pathway. Through this work, Cellugy will gain invaluable insights into formulating targeted strategies aimed at improving cellulose yield and productivity, paving the way for commercial viability and success.

Cristina Serrano, Senior Scientist at Ingenza, commented: “We are thrilled to join forces with Cellugy to explore strategies for improving bacterial cellulose production. From a scientist’s perspective, this project is an exciting opportunity to work with a new organism, which will in turn help us to showcase Ingenza’s capabilities and expand our ever-increasing technical knowledge.”

This partnership with Ingenza perfectly aligns with our commitment to driving sustainability in biotechnology. By combining the expertise of both companies, we aim to accelerate the development of the next generation of bio-solutions for sustainable ingredients for the personal care market.”

Deby Fapyane, Co-founder and Chief Scientific Officer, Cellugy

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ingenza Ltd. (2024, August 23). Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose. News-Medical. Retrieved on October 06, 2024 from https://www.news-medical.net/news/20240823/Ingenza-announces-partnership-with-Cellugy-to-investigate-the-potential-of-biofabricated-cellulose.aspx.

  • MLA

    Ingenza Ltd. "Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose". News-Medical. 06 October 2024. <https://www.news-medical.net/news/20240823/Ingenza-announces-partnership-with-Cellugy-to-investigate-the-potential-of-biofabricated-cellulose.aspx>.

  • Chicago

    Ingenza Ltd. "Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose". News-Medical. https://www.news-medical.net/news/20240823/Ingenza-announces-partnership-with-Cellugy-to-investigate-the-potential-of-biofabricated-cellulose.aspx. (accessed October 06, 2024).

  • Harvard

    Ingenza Ltd. 2024. Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose. News-Medical, viewed 06 October 2024, https://www.news-medical.net/news/20240823/Ingenza-announces-partnership-with-Cellugy-to-investigate-the-potential-of-biofabricated-cellulose.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ingenza appoints Steve Jones as its new Chief Financial Officer